Simon Wernhart
Overview
Explore the profile of Simon Wernhart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seth C, Schmid V, Mueller S, Haykowsky M, Foulkes S, Halle M, et al.
Herz
. 2025 Mar;
PMID: 40085207
Diabetes, obesity, and cardiovascular disease (CVD) represent an escalating global health challenge, contributing significantly to morbidity, mortality, and healthcare costs. Evidence from large cohort studies and clinical trials underscores the...
2.
Halle M, Wernhart S, Krane M
Eur Heart J
. 2024 Dec;
46(7):665-666.
PMID: 39656802
No abstract available.
3.
Vogel J, Carpinteiro A, Luedike P, Buehning F, Wernhart S, Rassaf T, et al.
Curr Heart Fail Rep
. 2024 May;
21(4):305-321.
PMID: 38809394
Purpose Of Review: Cardiac amyloidosis (CA) is a condition characterized by misfolding and extracellular deposition of proteins, leading to organ dysfunction. While numerous forms of CA exist, two subtypes dominate...
4.
Wernhart S, Rassaf T
Curr Heart Fail Rep
. 2024 May;
21(3):238-251.
PMID: 38696059
Purpose Of The Review: Cancer therapy-related cardiac dysfunction (CTRCD) has been identified as a threat to overall and cancer-related survival. Although aerobic exercise training (AET) has been shown to improve...
5.
Wernhart S, Michel L, Carpinteiro A, Luedike P, Rassaf T
Curr Heart Fail Rep
. 2024 Apr;
21(3):224-237.
PMID: 38635117
Purpose Of Review: Cardiac amyloidosis (CA) constitutes an important etiology of heart failure with preserved ejection fraction (HFpEF) or heart failure with mildly reduced ejection fraction (HFmrEF). Since patients with...
6.
Wernhart S, Rassaf T
Basic Res Cardiol
. 2024 Feb;
120(1):35-55.
PMID: 38353711
Cardiovascular diseases and cancer are the leading causes of death in the Western world and share common risk factors. Reduced cardiorespiratory fitness (CRF) is a major determinant of cardiovascular morbidity...
7.
Jakstaite A, Luedike P, Wernhart S, Kamler M, Ruhparwar A, Rassaf T, et al.
Int J Cardiol Heart Vasc
. 2023 Sep;
48:101263.
PMID: 37663612
Background: Multiple domains of quality of life (QoL) such as erectile function are not sufficiently investigated among left ventricular assist-device (LVAD) patients. We aimed to evaluate the prevalence of erectile...
8.
Wernhart S, Goertz A, Hedderich J, Papathanasiou M, Hoffmann J, Rassaf T, et al.
Eur J Heart Fail
. 2023 Aug;
25(10):1768-1780.
PMID: 37565370
Aims: Pulmonary capillary wedge pressure (PAWP) ≥25 mmHg during bicycle ergometry is recommended to uncover occult heart failure with preserved ejection fraction. We hypothesized that PAWP increase would differ in...
9.
Wernhart S, Weihe E, Totzeck M, Balcer B, Rassaf T, Luedike P
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445382
(1) Background: Cardiopulmonary exercise testing (CPET) has been suggested by the European Society of Cardiology (ESC) for assessing the exercise limitations of apparently healthy individuals, but data on elite athletes...
10.
Wernhart S, Balcer B, Rassaf T, Luedike P
J Clin Med
. 2023 Jun;
12(11).
PMID: 37297853
(1) Background: The exercise capacity of patients with a left ventricular assist device (LVAD) remains limited despite mechanical support. Higher dead space ventilation (V/V) may be a surrogate for right...